These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 3552595)

  • 61. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hemostatic parameters influenced by imipenem/cilastatin].
    Ziemen M; Shah PM; Henkel-Bussmann M; Breddin HK
    Infection; 1986; 14 Suppl 2():S138-42. PubMed ID: 3759248
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Meropenem: a review of its use in patients in intensive care.
    Hurst M; Lamb HM
    Drugs; 2000 Mar; 59(3):653-80. PubMed ID: 10776838
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Imipenem and cilastatin in acute osteomyelitis and suppurative arthritis. Therapy in infants and children.
    Freij BJ; Kusmiesz H; Shelton S; Nelson JD
    Am J Dis Child; 1987 Mar; 141(3):335-42. PubMed ID: 3544811
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibacterial activity of imipenem: the first thienamycin antibiotic.
    Kropp H; Gerckens L; Sundelof JG; Kahan FM
    Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Efficacy and tolerability of imipenem/cilastatin in infections at various sites].
    Grassi C; Baglioni A; Bonsignore G; Catena E; De Rose V; Grignani F; Lotti T; Orlandi O; Panichi G; Pavone Macaluso M
    G Ital Chemioter; 1986; 33(2-3):143-8. PubMed ID: 3479372
    [No Abstract]   [Full Text] [Related]  

  • 67. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.
    Standiford HC; Drusano GL; Bustamante CI; Rivera G; Forrest A; Tatem B; Leslie J; Moody M
    Antimicrob Agents Chemother; 1986 Mar; 29(3):412-7. PubMed ID: 3459390
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of uncomplicated gonorrhea with single-dose imipenem-cilastatin.
    Verdon MS; Judson FN; Ehret JM; Root CJ; Hook EW; McCormack WM; Frances CA; Draft K; Shands JW; Handsfield HH
    Antimicrob Agents Chemother; 1988 May; 32(5):773-4. PubMed ID: 3395105
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
    Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
    Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of imipenem/cilastatin in the empirical treatment of septicemia.
    Del Valle J; Noriega AR; Sanz F; Revilla AP; Otero JR
    Scand J Infect Dis Suppl; 1987; 52():20-5. PubMed ID: 3331040
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Chimura T; Morisaki N; Matsuo M
    Jpn J Antibiot; 1986 Jun; 39(6):1519-25. PubMed ID: 3463793
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Horii T; Noda K
    Jpn J Antibiot; 1986 Jun; 39(6):1601-6. PubMed ID: 3463800
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
    Mitsuhashi S
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
    Wang C; Pappas F; Cook T
    Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.
    Norrby SR; Eriksson M; Ottosson E
    Scand J Infect Dis; 1986; 18(4):371-4. PubMed ID: 3094139
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers.
    Drusano GL; Standiford HC; Bustamante CI; Forrest A; Rivera G; Tatem B; Schimpff SC
    Eur J Clin Microbiol; 1984 Oct; 3(5):468-70. PubMed ID: 6594235
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.
    Engelhard D; Shalit I; Stutman HR; Greenwood R; Griffis J; Marks MI
    Pediatr Pharmacol (New York); 1986; 5(4):273-9. PubMed ID: 3461422
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.